Skip to main content
Clinical Trials/NL-OMON22185
NL-OMON22185
Suspended
Not Applicable

The RAINBOW study: Rheumatoid Arthritis ImplemeNtation of Biological dose Optimization in real World

This is an investigator-initiated study, funded by the Sint Maartenskliniek0 sites320 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid Arthritis (RA)
Sponsor
This is an investigator-initiated study, funded by the Sint Maartenskliniek
Enrollment
320
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
This is an investigator-initiated study, funded by the Sint Maartenskliniek

Eligibility Criteria

Inclusion Criteria

  • Rheumatoid arthritis (clinical diagnosis of treating rheumatologist, fulfilled at any time point between start of the disease and inclusion) operationalized by DOT diagnosis 101\.
  • Being treated in a center in which the RAINBOW implementation project is starting

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials